ODP124 Sickle Cell Bone Disease and Response to Intravenous Bisphosphonates in Children

PURPOSE: To evaluate bone morbidity and the response to intravenous (IV) bisphosphonate therapy in children with Sickle Cell Disease (SCD). METHODS: We conducted a retrospective review of patient records from 2003 to 2019 at three Canadian pediatric tertiary care centers. Radiographs, magnetic reson...

Descripción completa

Detalles Bibliográficos
Autores principales: Todd Alexander, R, Grimbly, Chelsey, Ward, Leanne M, Escagedo, Patricia Diaz, Jaremko, Jacob L, Bruce, Aisha, Alos, Nathalie, Robinson, Marie-Eve, Konji, Victor N, Page, Marika, Simpson, Ewurabena, Pastore, Yves D, Girgis, Rose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Bone & Mineral Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624790/
http://dx.doi.org/10.1210/jendso/bvac150.365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624790/
http://dx.doi.org/10.1210/jendso/bvac150.365

Ejemplares similares